We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Nano Drug Crosses Blood-Brain Tumor Barrier

News   Jul 22, 2013

 
Nano Drug Crosses Blood-Brain Tumor Barrier
 
 
 

RELATED ARTICLES

The First Precision Medicine Clinical Trial for Dogs With Lung Cancer

News

A "ground-breaking" new study led by the Translational Genomics Research Institute (TGen) suggests that the HER2 gene that

same gene is the cause of lung cancer in many dogs. Their findings, published in the journal Clinical Cancer Research, offer novel avenues for precision medicine in dogs.

READ MORE

Kissing Loops Essential for Tumor Suppression

News

A team of researchers in the Marcia group at EMBL Grenoble have discovered that the tumour suppressor MEG3 adopts a complex three-dimensional structure to fulfil its function. Furthermore, they were able to fine-tune its activity by targeted manipulation of this architecture.

READ MORE

First Generic Version of EpiPen Is Approved

News

The U.S. Food and Drug Administration has approved the first generic version of EpiPen and EpiPen Jr (epinephrine) auto-injector for the emergency treatment of allergic reactions, including those that are life-threatening (anaphylaxis), in adults and pediatric patients who weigh more than 33 pounds.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Applied Sciences Drug Discovery

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE